rxstatShortages › Bazedoxifene Conjugated Estrogens

Bazedoxifene Conjugated Estrogens (Duavive) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 29, 2026

A shortage of Bazedoxifene Conjugated Estrogens is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.

A combination used to treat menopausal symptoms and help prevent osteoporosis.

Products affected
0 / 1
Reports on file
5

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Anticipated
DUAVIVE
20MG 0.45MG · TABLET (IMMEDIATE AND EXTENDED RELEASE) · PFIZER CANADA ULC
DIN 02432854 · Disruption of the manufacture of the drug.
Resolved
DUAVIVE
20MG 0.45MG · TABLET (IMMEDIATE AND EXTENDED RELEASE) · PFIZER CANADA ULC
DIN 02432854 · ended Jan 22, 2025 · Disruption of the manufacture of the drug.
Resolved
DUAVIVE
20MG 0.45MG · TABLET (IMMEDIATE AND EXTENDED RELEASE) · PFIZER CANADA ULC
DIN 02432854 · ended Aug 8, 2024 · Disruption of the manufacture of the drug.
Resolved
DUAVIVE
20MG 0.45MG · TABLET (IMMEDIATE AND EXTENDED RELEASE) · PFIZER CANADA ULC
DIN 02432854 · ended Jul 11, 2024 · Disruption of the manufacture of the drug.
Resolved
DUAVIVE
0.45MG 20MG · TABLET (IMMEDIATE AND EXTENDED RELEASE) · PFIZER CANADA ULC
DIN 02432854 · ended Jun 9, 2023 · Disruption of the manufacture of the drug.

What's happening

A manufacturer has told Health Canada it expects supply of Bazedoxifene Conjugated Estrogens to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Bazedoxifene Conjugated Estrogens is classified under “ESTROGENS” (ATC G03CC).

Recent changes

Common questions

What is Bazedoxifene Conjugated Estrogens used for?

A combination used to treat menopausal symptoms and help prevent osteoporosis.

When will Bazedoxifene Conjugated Estrogens be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Bazedoxifene Conjugated Estrogens in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (estrogens)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.